HONG KONG, May 22, 2026 - (ACN Newswire via SeaPRwire.com) - Recently, HR Asia, a leading authority in human resources media in Asia, officially announced its award results in 2026. Guotai Junan International Holdings Limited (“Guotai Junan International” or “GTJAI”, Stock Code: 1788.HK), a subsidiary of Guotai Haitong Group, has won two prestigious awards — “Best Companies to Work for in Asia” and “Tech Empowerment Award” — in recognition of its outstanding practices in workplace development, employee care, and digital enablement.HR Asia is a widely influential HR media brand in Asia. Through independent employee surveys and expert judging, it recognizes companies that demonstrate outstanding performance in employer branding, talent development, workplace culture, and technological innovation. The “Best Companies to Work for in Asia” award aims to honor companies that adhere to a people-oriented approach, build a high-quality workplace ecosystem, and foster the shared growth of employees and the organization. The “Tech Empowerment Award” recognizes companies that leverage innovative technologies to enhance employee productivity, engagement, and overall work efficiency, setting industry benchmarks in digital transformation and workplace empowerment. (The Human Resources team of GTJAI Accepted the Awards)GTJAI has always regarded talent as its core driving force. It continuously improves its systems for talent acquisition, development, incentives, and career progression, while building diversified career pathways and providing growth support that covers professional capabilities, management competencies, and an international perspective. At the same time, GTJAI places great emphasis on fostering an inclusive, equitable, and healthy workplace atmosphere, with a focus on employee experience and work-life balance, creating an open, collaborative, and positive team environment. In terms of technology empowerment, GTJAI drives the deep integration of financial technology with internal management, office collaboration, and business operations. By leveraging innovative technology solutions, it optimizes management processes, enhances collaboration efficiency, and improves employee work experience. Through digital tools, it boosts organizational efficiency and employee satisfaction, providing strong support for steady business development and global expansion.As a key international business platform under Guotai Haitong Group, GTJAI is headquartered in Hong Kong and serves global markets. It adheres to a compliant and prudent management philosophy, continuously building a competitive employer brand amid its business development while attracting and nurturing outstanding financial talent. The recognition of receiving two prestigious HR Asia 2026 awards affirms GTJAI’s efforts in employer brand building, talent management practices, and technology empowerment achievements, and will further enhance its brand image within Asia’s financial industry and human resources sector. GTJAI will take this award as an opportunity to fulfill corporate responsibilities, promote the shared growth of employees and the Company, enhance professional service capabilities and global market influence, leverage cross-border financial advantages, bring together top-tier talent, create long-term value for clients, provide a broad development platform for employees, and contribute to the development of Hong Kong as an international financial center.About GTJAIGuotai Junan International (Stock Code: 1788.HK), a subsidiary of Guotai Haitong Group, is the market leader and first mover for internationalization of Chinese Securities Company as well as the first Chinese securities broker listed on the Main Board of The Hong Kong Stock Exchange through initial public offering. Based in Hong Kong with subsidiaries in Singapore, Vietnam and Macau, GTJAI’s business covers major markets around the world, offering high-quality and diversified comprehensive financial services for clients' overseas asset allocation. Core business includes wealth management, institutional investor services, corporate finance services, investment management and other business. GTJAI has been assigned “Baa2” and “BBB+” long term issuer rating from Moody and Standard & Poor respectively, as well as an MSCI ESG “AAA” rating, Wind ESG “A” rating and SynTao Green Finance “A” rating in ESG. Additionally, its S&P Global ESG score leads 81% of its global peers. The controlling shareholder, Guotai Haitong Securities (Stock Code: 601211.SH/ 2611.HK), is the comprehensive financial provider with a long-term, sustainable and overall leading position in the China’s capital markets. For more information about GTJAI, please visit https://www.gtjai.com. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港, 2026年5月22日 - (亚太商讯 via SeaPRwire.com) - 近日，亚洲权威人力资源媒体HR Asia正式公布2026年度奖项评选结果，国泰海通集团下属公司国泰君安国际控股有限公司（"国泰君安国际"，股份代号：1788.HK）凭借在职场建设、员工关怀与数字化赋能等方面的优秀实践，一举斩获"亚洲最佳企业雇主"及"科技赋能奖"两项重要奖项。HR Asia是亚洲具有广泛影响力的人力资源专业媒体品牌，通过独立员工问卷调查与专业评审，评选在雇主品牌建设、人才发展、职场文化及科技创新等方面表现突出的企业。本次"亚洲最佳企业雇主"奖项，旨在表彰坚持以人为本、构建优质职场生态、推动员工与企业共同成长的优秀企业；"科技赋能奖"用于表彰运用创新技术提升员工生产力、敬业度与整体工作效率，在数字化转型与职场赋能方面树立行业标杆的企业。 （国泰君安国际人力资源团队登台领奖）国泰君安国际始终视人才为核心动力，持续完善人才引进、培养、激励与发展体系，搭建多元化职业发展通道，提供覆盖专业能力、管理能力与国际化视野的成长支持。同时，公司注重构建包容、平等、健康的职场氛围，关注员工体验与工作生活平衡，营造开放协作、积极向上的团队环境。在科技赋能方面，国泰君安国际推动金融科技与内部管理、办公协同、业务运营深度融合，通过创新技术解决方案优化管理流程、提升协作效率、改善员工工作体验，以数字化工具提升组织运行效率与员工满意度，为业务稳健发展与全球化布局提供有力支撑。作为国泰海通集团旗下重要的国际化业务平台，国泰君安国际立足香港、服务全球市场，坚守合规稳健经营理念，在业务发展中持续打造具有竞争力的雇主品牌，吸引并培养优秀金融人才。此次荣获HR Asia 2026两项权威奖项，是对国泰君安国际雇主品牌建设、人才管理实践与科技赋能成果的认可，也将进一步提升其在亚洲金融行业及人力资源领域的品牌形象。国泰君安国际将以此次获奖为契机，践行企业责任，推动员工与企业共同成长，提升专业服务能力与全球市场影响力，发挥跨境金融优势，汇聚优秀人才，为客户创造长期价值，为员工提供广阔发展平台，为香港国际金融中心建设贡献力量。关于国泰君安国际国泰海通集团下属公司国泰君安国际（股票代号：1788.HK），是中国证券公司国际化的先行者和引领者，公司是首家通过IPO于香港联合交易所主板上市的中资证券公司。国泰君安国际以香港为业务基地，并在新加坡、越南和澳门设立子公司，业务覆盖全球主要市场，为客户境外资产配置提供高质量、多元化的综合性金融服务，核心业务包括财富管理、机构投资者服务、企业融资服务、投资管理等。目前，国泰君安国际已分别获得穆迪和标准普尔授予"Baa2"及"BBB+"长期发行人评级，MSCI ESG"AAA"评级, Wind ESG"A"评级及商道融绿ESG"A"评级，同时其标普全球ESG评分领先全球81%同业。公司控股股东国泰海通证券（股票代号：601211.SH/2611.HK）为中国资本市场长期、持续、全面领先的综合金融服务商。更多关于国泰君安国际的信息请见:https://www.gtjai.com Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, May 22, 2026 - (ACN Newswire via SeaPRwire.com) - Everest Medicines announced that its substantial shareholder, CBC Group, purchased 600,500 ordinary shares of the Company on the market from 20 May 2026 to 21 May 2026. The total consideration for the transaction was approximately HK$19.2 million, representing an average purchase price of approximately HK$31.91 per share.The purchase represents a further increase in CBC Group’s shareholding in the Company. Since December 2025, CBC Group and the Directors have cumulatively purchased more than 3.062 million shares of the Company on the market for a total consideration of more than HK$113.8 million in aggregate. Additionally, Mr. Wei Fu, a non-executive Director, the honorary chairman of the Board and a substantial shareholder of the company, increased his holdings of the Company's shares twice on 27 March and 14 May 2026. He purchased 860,000 shares and 660,000 shares respectively, with corresponding transaction amounts of approximately HK$32.7 million and HK$20.7 million. CBC Group and the Directors stated that, based on their firm confidence in the Company’s future prospects and long-term development, and subject to compliance with the applicable laws and regulations, they do not rule out the possibility of further increasing their shareholdings in the Company when appropriate.The increased shareholding comes as CBC Group recently announced a merger agreement with GHO Capital, a leading European healthcare-specialist investment firm. The transaction will be structured as a 50:50 merger of equals and is expected to close in early 2027. Following completion, the combined platform is expected to manage more than US$21 billion in assets, potentially becoming the world’s largest healthcare-focused investment management platform. The combined entity will span North America, Europe, and Asia-Pacific — regions that together account for approximately 90% of global healthcare R&D investment.According to analysts, the merger between CBC Group and GHO Capital is expected to further enhance resource synergy and global expansion capabilities for Everest Medicines. Everest Medicines achieved 142% year-over-year revenue growth in 2025, with core product NEFECON® generating RMB 1.443 billion in sales, representing over 300% year-over-year growth. Under the Company's previously announced 2030 Strategy, Everest Medicines aims to achieve revenue exceeding RMB 15 billion and expand its commercialized product portfolio to more than 20 products by 2030, accelerating its transformation into a global integrated biopharmaceutical company. With the further integration of global resource networks, the Company is expected to accelerate the internationalization of its innovative products and its global commercial footprint. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港, 2026年5月22日 - (亚太商讯 via SeaPRwire.com) - 云顶新耀发布公告称，公司主要股东康桥资本于2026年5月20日至21日期间，通过公开市场购入公司普通股60.05万股，交易总金额约1920万港元，平均价格约为每股31.91港元。据悉，此次购入为康桥资本对云顶新耀股份的再度增持。自2025年12月以来，康桥资本及公司董事已连续在公开市场累计购入超过306.2万股公司股份，累计交易总金额超过1.138亿港元。另外，公司非执行董事、董事会荣誉主席兼主要股东傅唯先生于2026年3月27日及5月14日两次增持公司股份，分别购入86万股和66万股，总金额约3270万港元及2070万港元。康桥资本及公司董事表示，基于对公司未来前景与长期发展的坚定信心，在遵守相关法律法规的前提下，不排除未来在适当时候进一步增持公司股份的可能性。此次增持正值康桥资本宣布与欧洲领先的医疗健康专业投资机构GHO Capital达成合并协议之际。双方采用50：50平等合并模式，预计于2027年初完成。合并后平台资产管理规模将超过210亿美元，有望成为全球规模最大的医疗健康投资资产管理平台，覆盖北美、欧洲及亚太地区，三大区域合计占全球医疗健康研发投入约90%。分析人士认为，康桥资本与GHO Capital的合并，将进一步增强云顶新耀国际化发展的资源协同与全球布局能力。云顶新耀2025年营收同比增长142%，核心产品耐赋康®销售收入达14.43亿元，同比增长超300%。根据公司此前发布的2030战略，云顶新耀目标到2030年实现营收突破150亿元、商业化产品超20款，加速向全球化综合性生物制药公司迈进。随着全球资源网络进一步整合，公司有望加快创新产品国际化及全球商业布局。 Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com